Contact
searchSearch
HMP Global

Esophageal Diseases News

Research Highlights
GLP-1 Receptor Agonists Linked to Increased Risk of Gallstones and GERD
01/14/2026
Jessica Garlewicz
A systematic review of over 100,000 patients confirms a higher risk of cholelithiasis and GERD with GLP-1RAs, particularly in weight-loss-focused and high-dose formulations.
A systematic review of over 100,000 patients confirms a higher risk of cholelithiasis and GERD with GLP-1RAs, particularly in weight-loss-focused and high-dose formulations.
A systematic review of over...
01/14/2026
Gastroenterology
Research Highlights
High Prevalence of Gut-Brain Interaction Disorders Found in Patients With Refractory Reflux Symptoms
06/24/2025
Jessica Garlewicz
Identifying E-DGBIs in this population may guide more effective, targeted management strategies and prevent unnecessary invasive procedures.
Identifying E-DGBIs in this population may guide more effective, targeted management strategies and prevent unnecessary invasive procedures.
Identifying E-DGBIs in this...
06/24/2025
Gastroenterology
News
Nationwide Study Links Achalasia to Elevated Long-Term Mortality Risk
04/15/2025
Jessica Garlewicz
Clinicians may need to consider routine assessments for esophageal malignancy and respiratory complications as part of a long-term care strategy.
Clinicians may need to consider routine assessments for esophageal malignancy and respiratory complications as part of a long-term care strategy.
Clinicians may need to consider...
04/15/2025
Gastroenterology
News
Dupilumab Improves Quality of Life and Symptoms in Eosinophilic Esophagitis
03/17/2025
Jessica Garlewicz
Weekly treatment with dupilumab reduced the frequency and severity of EoE symptoms including emotional well-being and sleep disturbance.
Weekly treatment with dupilumab reduced the frequency and severity of EoE symptoms including emotional well-being and sleep disturbance.
Weekly treatment with dupilumab...
03/17/2025
Gastroenterology
News
Upper Gl Mucosal Damage Associated With Parkinson's Disease
10/18/2024
Jessica Garlewicz
Upper gastrointestinal (GI) mucosal damage was associated with elevated risk of developing Parkinson's disease.
Upper gastrointestinal (GI) mucosal damage was associated with elevated risk of developing Parkinson's disease.
Upper gastrointestinal (GI)...
10/18/2024
Gastroenterology
News
Metabolic Health Does Not Protect Against Erosive Esophagitis in Adults With Obesity
03/08/2024
Jolynn Tumolo
Waist circumference, higher body mass index were associated with higher risks of developing erosive esophagitis.
Waist circumference, higher body mass index were associated with higher risks of developing erosive esophagitis.
Waist circumference, higher body...
03/08/2024
Gastroenterology
News
1 in 5 Patients with Erosive Esophagitis Cycles Through PPIs
02/23/2024
Jolynn Tumolo
Persistence with any proton pump inhibitor therapy was low among patients with erosive esophagitis, researchers found.
Persistence with any proton pump inhibitor therapy was low among patients with erosive esophagitis, researchers found.
Persistence with any proton pump...
02/23/2024
Gastroenterology
News
The Link Between Antibiotic Use and EoE for Mothers and Infants
02/14/2024
Priyam Vora
The findings of a recent study in Denmark offer noteworthy insights and have significant implications for healthcare practices.
The findings of a recent study in Denmark offer noteworthy insights and have significant implications for healthcare practices.
The findings of a recent study...
02/14/2024
Gastroenterology
News
Caffeine Overdose Causes Severe Erosive Esophagitis
02/10/2024
Jolynn Tumolo
In a rare case, the ingestion of excessive caffeine tablets caused “chemical” erosive esophagitis.
In a rare case, the ingestion of excessive caffeine tablets caused “chemical” erosive esophagitis.
In a rare case, the ingestion of...
02/10/2024
Gastroenterology
News
Vonoprazan Shows Efficacy in Healing of Erosive Esophagitis
02/08/2024
Jolynn Tumolo
The potassium-competitive acid blocker proved superior to the proton pump inhibitor lansoprazole in some aspects of healing erosive esophagitis.
The potassium-competitive acid blocker proved superior to the proton pump inhibitor lansoprazole in some aspects of healing erosive esophagitis.
The potassium-competitive acid...
02/08/2024
Gastroenterology

News

Research Review
New Meta-Analysis Highlights Burden of MASLD Among IBD Patients
02/03/2026
Rebecca Mashaw
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from...
02/03/2026
Gastroenterology
Emerging Therapies
EC Plus FOLFIRI Improves Response Rates in First-Line BRAF V600E–Mutant Metastatic Colorectal Cancer
01/14/2026
Jessica Garlewicz
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating...
01/14/2026
Gastroenterology
Research Highlights
Short Course Radiation and ctDNA for Rectal Cancer
01/14/2026
Jessica Garlewicz
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the...
01/14/2026
Gastroenterology
Research Highlights
Cumulative Social Risk Linked to Poorer Survival in Stage III Colorectal Cancer
01/14/2026
Jessica Garlewicz
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found...
01/14/2026
Gastroenterology
Research Highlights
Persistent MASLD Greatly Increases Diabetes and Cardiovascular Risks, Study Finds
12/15/2025
Rebecca Mashaw
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links...
12/15/2025
Gastroenterology
Research Highlights
Sex-Specific Risks Highlight MASLD Burden Across Women’s Lifespan
12/11/2025
Rebecca Mashaw
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD...
12/11/2025
Gastroenterology
Conference Coverage
Resmetirom Reduces Portal Hypertension Risk and Fibrosis Markers in MASH Cirrhosis at 2 Years
11/04/2025
Jessica Garlewicz
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients...
11/04/2025
Gastroenterology
Conference Coverage
Tirzepatide Bests Semaglutide in Reducing Cardiovascular Events and Mortality in Patients With MASLD/MASH
11/04/2025
Jessica Garlewicz
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was...
11/04/2025
Gastroenterology
Conference Coverage
E-Cigarette Use and Risk of Peptic Ulcer Disease: Findings from a National Cohort
10/27/2025
Rebecca Mashaw
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at...
10/27/2025
Gastroenterology
Research Highlights
Liquid Biopsy Shows Potential in Cholangiocarcinoma Care
10/09/2025
Rebecca Mashaw
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights...
10/09/2025
Gastroenterology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use